Characteristics of Clinical Trials Launched Early in the COVID-19 Pandemic in the US and in France

被引：1

作者：

Raimond, Veronique ^{[1
]}

Mousques, Julien ^{[2
]}

Avorn, Jerry ^{[1
,3
]}

Kesselheim, Aaron S. ^{[1
,3
]}

机构：

[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 75 Francis St, Boston, MA 02115 USA

[2] Inst Res & Informat Hlth Econ IRDES, 117 Bis Rue Manin, F-75019 Paris, France

[3] Harvard Med Sch, Boston, MA 02115 USA

来源：

JOURNAL OF LAW MEDICINE & ETHICS | 2021年 / 49卷 / 01期

关键词：

COVID-19; Clinical Trial; United States; France; Hierarchical Classification;

D O I：

10.1017/jme.2021.19

中图分类号：

B82 [伦理学（道德学）];

学科分类号：

摘要：

Based on hierarchical classification and logistic regression of early US and French COVID-19 clinical trials we show that despite the registration of a large number of trials, only a minority had characteristics usually associated with providing robust and relevant evidence.

引用

页码：139 / 151

页数：13

共 50 条

[1] Trends in Oncology Clinical Trials Launched Before and During the COVID-19 Pandemic
Lamont, Elizabeth B.
Diamond, Sheila S.
Katriel, Ron G.
Ensign, Lisa L.
Liu, Jingshu
Rusli, Emelly
Alexander, G. Caleb
[J]. JAMA NETWORK OPEN, 2021, 4 (01)
[2] Clinical trials and the COVID-19 pandemic
Retsas, Spyros
[J]. HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2020, 23 (01): : 4 - 5
[3] Clinical trials, adaptability and the COVID-19 pandemic
Eskander, Ramez N.
Pothuri, Bhavana
Randall, Leslie
O'Malley, David
Slomovitz, Brian
Moore, Kathleen
Coleman, Robert
Herzog, Thomas
Monk, Bradley J.
Copeland, Larry
[J]. GYNECOLOGIC ONCOLOGY REPORTS, 2021, 35
[4] Clinical trials during COVID-19 pandemic
不详
[J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2020, 204 (09): : E88 - E89
[5] The COVID-19 Pandemic in the US A Clinical Update
Omer, Saad B.
Malani, Preeti
del Rio, Carlos
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (18): : 1767 - 1768
[6] Characteristics of academic publications, preprints, and registered clinical trials on the COVID-19 pandemic
Gianola, Silvia
Jesus, Tiago S.
Bargeri, Silvia
Castellini, Greta
[J]. PLOS ONE, 2020, 15 (10):
[7] EARLY COVID-19 PANDEMIC IN GERMANY: PATIENT CHARACTERISTICS AND CLINICAL OUTCOMES
Pacis, S.
Maywald, U.
Wilke, T.
Ghiani, M.
[J]. VALUE IN HEALTH, 2022, 25 (01) : S23 - S24
[8] Ongoing Clinical Trials for the Management of the COVID-19 Pandemic
Lythgoe, Mark P.
Middleton, Paul
[J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2020, 41 (06) : 363 - 382
[9] Impact of the COVID-19 Pandemic on Cancer Clinical Trials
Judy C. Boughey
Rebecca A. Snyder
Olga Kantor
Linda Zheng
Akhil Chawla
Toan T. Nguyen
Shauna L. Hillman
Olwen M. Hahn
Sumithra J. Mandrekar
Christina L. Roland
[J]. Annals of Surgical Oncology, 2021, 28 : 7311 - 7316
[10] The COVID-19 pandemic: a catalyst to improve clinical trials
Prakriti Gaba
Deepak L. Bhatt
[J]. Nature Reviews Cardiology, 2020, 17 : 673 - 675

← 1 2 3 4 5 →